A multi-centre randomised study to evaluate the efficacy of Betaferon-interferon-beta-1b (IFNB-1B) 500 mcg therapy in the induction of tolerance to IFNB in MS patients with neutralising antibodies (NAbs) to IFNB-1a (Rebif).
Phase of Trial: Phase II
Latest Information Update: 26 May 2011
At a glance
- Drugs Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 26 May 2011 New trial record